 HAMILTON, BERMUDA , Jan. 24, 2023 GLOBE NEWSWIRE Interim analysis of Australian NASAR trial in seasonal allergic rhinitis shows statistically significant improvement with Bentrio in nasal symptom primary endpoint over saline nasal spray comparator NASAR main trial phase completed; full read-out expected in Q2 2023 Top line data from COVAMID trial in acute COVID-19... The post Altamira Therapeutics Provides Update on Clinical Trials with Bentrio appeared first on DKODING... 